Prescription drug · ANDA
Methylergonovine Maleate NDC 0517-0740
Methylergonovine maleate .2 mg/mL · Injection, Solution · Intramuscular, Intravenous · American Regent, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0517-0740-20 | 0051707402000517074020 | 20 VIAL, SINGLE-DOSE in 1 CARTON (0517-0740-20) / 1 mL in 1 VIAL, SINGLE-DOSE (0517-0740-01)Marketed from Jun 21, 2010 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Methylergonovine Maleate
- Generic name (nonproprietary)
- methylergonovine maleate
- Active ingredients
- Methylergonovine maleate — .2 mg/mL
- Dosage form
- Injection, Solution
- Route
- Intramuscular, Intravenous
- Labeler
- American Regent, Inc.NDC labeler code 0517
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 090193
- Marketing start
- Listing expires
- Other FDA classes
- Ergolines (Chemical structure)
- Identifiers
- Product ID 0517-0740_719ae836-9739-4cd3-8a4e-0eb6ca4bd75cSPL ID 719ae836-9739-4cd3-8a4e-0eb6ca4bd75cSPL set ID a9a3079e-b62b-4858-920e-d8f5cb38481eRxCUI 996828UNII IR84JPZ1RK
- Pharmacologic class
- Ergot Derivative
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400517074020followed by a unit qualifier and the quantityPackage 00517-0740-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Following delivery of the placenta, for routine management of uterine atony, hemorrhage and subinvolution of the uterus. For control of uterine hemorrhage in the second stage of labor following delivery of the anterior shoulder.
Excerpt only. Read the full label for complete information.
About NDC 0517-0740
- What is NDC 0517-0740?
- 0517-0740 is the product NDC for Methylergonovine Maleate, Methylergonovine maleate .2 mg/mL injection, solution, listed with the FDA by American Regent, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Methylergonovine Maleate.
- What is the active ingredient?
- Methylergonovine maleate.
- Who is the labeler?
- American Regent, Inc., NDC labeler code 0517. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Methylergonovine Maleate?
- 13 other product NDCs are listed under this name. See all Methylergonovine Maleate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Methylergonovine Maleate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Methylergonovine Maleate | Methylergonovine maleate .2 mg/1 | TabletOral | Major Pharmaceuticals | 0904-7282 | 00904-7282-10 |
| Methylergonovine Maleate | Methylergonovine maleate .2 mg/1 | TabletOral | American Health Packaging | 60687-813 | 60687-0813-94 |
| Methylergonovine Maleate | Methylergonovine maleate .2 mg/1 | TabletOral | Volley Pharmaceuticals, LLC | 83400-100 | 83400-0100-1283400-0100-28 |
| Methylergonovine Maleate | Methylergonovine maleate .2 mg/mL | InjectionIntravenous | HF Acquisition Co LLC, DBA HealthFirst | 51662-1556 | 51662-1556-02 |
| Methylergonovine Maleate | Methylergonovine maleate .2 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | 16571-735 | 16571-0735-0116571-0735-1716571-0735-21+1 more |
| Methylergonovine Maleate | Methylergonovine maleate .2 mg/1 | TabletOral | Teva Pharmaceuticals USA, Inc. | 0093-3655 | 00093-3655-2200093-3655-28 |
| Methylergonovine Maleatemethylergonovine | Methylergonovine maleate .2 mg/1 | TabletOral | Amneal Pharmaceuticals NY LLC | 69238-1605 | 69238-1605-0269238-1605-08 |
| Methylergonovine Maleate | Methylergonovine maleate .2 mg/1 | TabletOral | Granules Pharmaceuticals Inc. | 70010-786 | 70010-0786-1270010-0786-28 |
| Methylergonovine Maleate | Methylergonovine maleate .2 mg/mL | InjectionIntravenous | Breckenridge Pharmaceutical, Inc. | 51991-144 | 51991-0144-17 |
| Methylergonovine Maleate | Methylergonovine maleate .2 mg/mL | InjectionIntravenous | Bryant Ranch Prepack | 63629-2074 | 63629-2074-01 |
Other NDCs under ANDA 090193
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Methylergonovine Maleate | Methylergonovine maleate .2 mg/mL | Injection, SolutionIntramuscular, Intravenous | HF Acquisition Co. LLC. DBA HealthFirst | 51662-1668 |